col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


100 Results       Page 1

 [1] 
Baishideng Publishing Group Co : World Journal of Gastroenterology
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―09 COVID-19 associated liver injury: A general review with special consideration of pregnancy and obstetric outcomes Katherine M. Cooper, Alessandro Colletta, Alison M. Asirwatham, Tiffany A. Moore Simas, Deepika Devuni
2 [GO] 2022―Oct―28 Interaction between gut microbiota and COVID-19 and its vaccines John S M Leung
3 [GO] 2022―Oct―18 COVID-19 and hepatorenal syndrome Henry H L Wu, Varinder S Athwal, Philip A Kalra, Rajkumar Chinnadurai
4 [GO] 2022―Oct―18 Effects of COVID-19 on the liver: The experience of a single center Valentina Liakina, Ieva Stundiene, Gabriele Milaknyte, Ramune Bytautiene, Rosita Reivytyte, Roma Puronaite, et al. (+2)
5 [GO] 2022―Oct―18 SARS-CoV-2-induced liver injury: A review article on the high-risk populations, manifestations, mechanisms, pathological changes, management, and outcomes Alvin Oliver Payus, Malehah Mohd Noh, Nornazirah Azizan, Raman Muthukaruppan Chettiar
6 [GO] 2022―Sep―29 Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19 Ricardo Ulises Macías-Rodríguez, Alberto Adrián Solís-Ortega, Victoria J Ornelas-Arroyo, Astrid Ruiz-Margáin, Maria Sarai González-Huezo, Nestor A Urdiales-Morán, et al. (+9)
7 [GO] 2022―Sep―23 SARS-CoV-2 and the pancreas: What do we know about acute pancreatitis in COVID-19 positive patients? Giuseppe Brisinda, Maria Michela Chiarello, Giuseppe Tropeano, Gaia Altieri, Caterina Puccioni, Pietro Fransvea, Valentina Bianchi
8 [GO] 2022―Jul―01 Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Kuldeep Dhama, Sang-Soo Lee
9 [GO] 2022―May―17 Review on acute pancreatitis attributed to COVID-19 infection Takumi Onoyama, Hiroki Koda, Wataru Hamamoto, Shiho Kawahara, Yuri Sakamoto, Taro Yamashita, et al. (+5)
10 [GO] 2022―Apr―24 Aspartate transferase-to-platelet ratio index-plus: A new simplified model for predicting the risk of mortality among patients with COVID-19 Ali Madian, Ahmed Eliwa, Hytham Abdalla, Haitham A Azeem Aly
11 [GO] 2022―Apr―14 COVID-19 and liver dysfunction: What nutritionists need to know Ming-Ke Wang, Xue-Lu Yu, Li-Yun Zhou, Hong-Mei Si, Ju-Fen Hui, Deng-Yong Hou, et al. (+2)
12 [GO] 2022―Mar―16 Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship Damiano D’Ardes, Andrea Boccatonda, Giulio Cocco, Stefano Fabiani, Ilaria Rossi, Marco Bucci, et al. (+3)
13 [GO] 2022―Feb―07 COVID-19, liver dysfunction and pathophysiology: A conceptual discussion Jucier Gonçalves Júnior
14 [GO] 2022―Jan―24 Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients Arunkumar Krishnan, Laura Prichett, Xueting Tao, Saleh A Alqahtani, James P Hamilton, Esteban Mezey, et al. (+5)
15 [GO] 2022―Jan―13 Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs Andrzej S Tarnawski, Amrita Ahluwalia
16 [GO] 2021―Dec―23 Strategy for the control of drug-induced liver injury due to investigational treatments/drugs for COVID-19 Ken Sato, Yuichi Yamazaki, Toshio Uraoka
17 [GO] 2021―Dec―09 COVID-19 and gut immunomodulation Koushik Roy, Sidra Agarwal, Rajib Banerjee, Manash K Paul, Prabhat K Purbey
18 [GO] 2021―Dec―09 Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar Muhammad Umair Khan, Kamran Mushtaq, Deema Hussam Alsoub, Phool Iqbal, Fateen Ata, Hammad Shabir Chaudhry, et al. (+9)
19 [GO] 2021―Dec―09 COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations Abhishek Bhurwal, Carlos D Minacapelli, Evan Orosz, Kapil Gupta, Christopher Tait, Ishita Dalal, et al. (+3)
20 [GO] 2021―Dec―09 Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, Amir Hossein Abdolghaffari
21 [GO] 2021―Dec―01 SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted Henu Kumar Verma, LVKS Bhaskar
22 [GO] 2021―Nov―25 COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future Muhammad Raheel Anjum, Jodie Chalmers, Rizwana Hamid, Neil Rajoriya
23 [GO] 2021―Nov―25 SARS-CoV-2 infection in liver transplant recipients: A complex relationship Ricardo Wesley Alberca, Gil Benard, Gabriela Gama Freire Alberca, Maria Notomi Sato
24 [GO] 2021―Nov―19 COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms Carlo Romano Settanni, Gianluca Ianiro, Francesca Romana Ponziani, Stefano Bibbò, Jonathan Philip Segal, Giovanni Cammarota, Antonio Gasbarrini
25 [GO] 2021―Nov―10 Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease David Bernstein, Nitzan Roth, Angela Kim, Marica Epstein, David Hirschwerk, Charlotte L Kvasnovsky, Sanjaya K Satapathy
26 [GO] 2021―Nov―10 Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study Shimaa Afify, Basem Eysa, Fatma Abdel Hamid, Omnia M Abo-Elazm, Mohamed A Edris, Rabab Maher, et al. (+4)
27 [GO] 2021―Nov―10 Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic Caterina Sagnelli, Mariantonietta Pisaturo, Caterina Curatolo, Alessio Vinicio Codella, Nicola Coppola, Evangelista Sagnelli
28 [GO] 2021―Nov―05 Gut microbiota in a population highly affected by obesity and type 2 diabetes and susceptibility to COVID-19 Jaime García-Mena, Karina Corona-Cervantes, Daniel Cuervo-Zanatta, Tizziani Benitez-Guerrero, Juan Manuel Vélez-Ixta, Norma Gabriela Zavala-Torres, et al. (+6)
29 [GO] 2021―Oct―27 Gastrointestinal and hepatic involvement during COVID-19 pandemic: A focus on pediatric population and possible future implications Rossella Sica, Serena Pennoni, Laura Penta, Sara Riccioni, Giuseppe Di Cara, Alberto Verrotti
30 [GO] 2021―Oct―27 Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study Hend Ibrahim Shousha, Shimaa Afify, Rabab Maher, Noha Asem, Eman Fouad, Ehab F Mostafa, et al. (+12)
31 [GO] 2021―Oct―19 Impact of COVID-19 pandemic on the neuropsychiatric status of Wilson’s disease Giuseppe Lanza, Massimiliano Godani, Raffaele Ferri, Alberto Raggi
32 [GO] 2021―Oct―19 Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis - with impact on gastrointestinal tract Izabela Berdowska, Malgorzata Matusiewicz
33 [GO] 2021―Oct―19 Evaluation of botanicals as potential COVID-19 symptoms terminator Ufuk Koca Caliskan, Methiye Mancak Karakus
34 [GO] 2021―Sep―29 Gastrointestinal symptoms in patients with COVID-19: Is there a relationship with mortality and new variations of SARS-CoV-2? Igor Braga Ribeiro, Diogo Turiani Hourneaux de Moura, Eduardo Guimarães Hourneaux de Moura
35 [GO] 2021―Sep―23 Liver disease in the era of COVID-19: Is the worst yet to come? Ivana Mikolasevic, Dorotea Bozic, Tajana Pavić, Alen Ruzic, Goran Hauser, Marija Radic, et al. (+4)
36 [GO] 2021―Sep―14 Liver-spleen axis dysfunction in COVID-19 Sara Cococcia, Marco Vincenzo Lenti, Giovanni Santacroce, Giovanna Achilli, Federica Borrelli de Andreis, Antonio Di Sabatino
37 [GO] 2021―Sep―14 Environmental perspectives of COVID-19 outbreaks: A review Palas Samanta, Apurba Ratan Ghosh
38 [GO] 2021―Sep―09 Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals Nancy Vargas-Mendoza, Jazmín García-Machorro, Marcelo Angeles-Valencia, Marlet Martínez-Archundia, Eduardo Osiris Madrigal-Santillán, Ángel Morales-González, et al. (+2)
39 [GO] 2021―Sep―09 Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition Danijela Ristic-Medic, Snjezana Petrovic, Aleksandra Arsic, Vesna Vucic
40 [GO] 2021―Sep―01 Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19 Alejandro Campos-Murguía, Berenice M Román-Calleja, José A González-Regueiro, Ivonne Hurtado-Díaz-de-León, Alberto Adrián Solís-Ortega, Nayelli C Flores-García, et al. (+3)
41 [GO] 2021―Sep―01 Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future Chiara Viganò, Giacomo Mulinacci, Andrea Palermo, Donatella Barisani, Lorena Pirola, Maria Fichera, et al. (+2)
42 [GO] 2021―Aug―24 Intestinal ischemic manifestations of SARS-CoV-2: Results from the ABDOCOVID multicentre study Lorenzo Norsa, Pietro Andrea Bonaffini, Maja Caldato, Cristiana Bonifacio, Aurelio Sonzogni, Amedeo Indriolo, et al. (+15)
43 [GO] 2021―Aug―10 Gastrointestinal mucosal immunity and COVID-19 Tsvetelina Velikova, Violeta Snegarova, Alexander Kukov, Hristiana Batselova, Antoaneta Mihova, Radislav Nakov
44 [GO] 2021―Aug―03 Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis Samuel D Johnson, Omalla A Olwenyi, Namita Bhyravbhatla, Michellie Thurman, Kabita Pandey, Elizabeth A Klug, et al. (+8)
45 [GO] 2021―Jul―26 Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management Dina Zakaria Mohamed, Mai El-Sayed Ghoneim, Sally El-Sayed Abu-Risha, Ramy Ahmed Abdelsalam, Mohamed Abdelhalem Farag
46 [GO] 2021―Jul―19 Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives Yi-Ke Huang, Yu-Jia Li, Bin Li, Pan Wang, Qing-Hua Wang
47 [GO] 2021―Jul―14 Impact of COVID-19 on the clinical status of patients with Wilson disease Yu-Pei Zhuang, Hao-Jie Zhong
48 [GO] 2021―Jul―11 Impact of COVID-19 on the clinical status of patients with Wilson disease Yu-Pei Zhuang, Hao-Jie Zhong
49 [GO] 2021―Jul―11 Inflammatory effect on the gastrointestinal system associated with COVID-19 Paulina Delgado-Gonzalez, Carlos A Gonzalez-Villarreal, Jorge A Roacho-Perez, Adriana G Quiroz-Reyes, Jose Francisco Islas, Juan Luis Delgado-Gallegos, et al. (+3)
50 [GO] 2021―Jul―11 Abdominal and gastrointestinal manifestations in COVID-19 patients: Is imaging useful? Piero Boraschi, Luigi Giugliano, Giuseppe Mercogliano, Francescamaria Donati, Stefania Romano, Emanuele Neri
51 [GO] 2021―Jul―11 Liver dysfunction and SARS-CoV-2 infection Abraham Edgar Gracia-Ramos, Joel Omar Jaquez-Quintana, Raúl Contreras-Omaña, Moises Auron
52 [GO] 2021―Jul―05 Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic Riccardo Inchingolo, Fabrizio Acquafredda, Michele Tedeschi, Letizia Laera, Gianmarco Surico, Alessia Surgo, et al. (+4)
53 [GO] 2021―Jul―05 Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence Marko Kumric, Tina Ticinovic Kurir, Dinko Martinovic, Piero Marin Zivkovic, Josko Bozic
54 [GO] 2021―Jun―25 COVID-19 and its effects on the digestive system Ting-Ting Cao, Gu-Qin Zhang, Emily Pellegrini, Qiu Zhao, Jin Li, Lin-jie Luo, Hua-Qin Pan
55 [GO] 2021―Jun―25 Neuropilin-1: A feasible link between liver pathologies and COVID-19 Aitor Benedicto, Iñigo García-Kamiruaga, Beatriz Arteta
56 [GO] 2021―Jun―17 Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review Carmelina Calitri, Ilaria Fumi, Maria Giovanna Ignaccolo, Elena Banino, Stefania Benetti, Maria Maddalena Lupica, et al. (+3)
57 [GO] 2021―Jun―17 COVID-19-associated diarrhea Klara Megyeri, Áron Dernovics, Zaid I I Al-Luhaibi, András Rosztóczy
58 [GO] 2021―Jun―08 COVID-19 and pediatric fatty liver disease: Is there interplay? Anna Di Sessa, Francesca Lanzaro, Sarah Zarrilli, Vittorio Picone, Stefano Guarino, Emanuele Miraglia del Giudice, Pierluigi Marzuillo
59 [GO] 2021―Jun―08 High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study Verena Zerbato, Stefano Di Bella, Mauro Giuffrè, Anna Wladyslawa Jaracz, Ylenia Gobbo, Diego Luppino, et al. (+8)
60 [GO] 2021―Jun―08 Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury Dan-Dan Zhu, Xue-Mei Tan, Li-Qing Lu, Si-Jia Yu, Ru-Li Jian, Xin-Fang Liang, et al. (+6)
61 [GO] 2021―Jun―08 Liver injury in COVID-19: Detection, pathogenesis, and treatment Yue Cai, Li-Ping Ye, Ya-Qi Song, Xin-Li Mao, Li Wang, Yan-Zhi Jiang, et al. (+2)
62 [GO] 2021―May―26 Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology Sarah Musa Hammoudeh, Arabella Musa Hammoudeh, Poorna Manasa Bhamidimarri, Bassam Mahboub, Rabih Halwani, Qutayba Hamid, et al. (+2)
63 [GO] 2021―May―20 COVID-19 in normal, diseased and transplanted liver Alessandro Signorello, Ilaria Lenci, Martina Milana, Giuseppe Grassi, Leonardo Baiocchi
64 [GO] 2021―May―13 Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19 Byungchang Jin, Rajan Singh, Se Eun Ha, Hannah Zogg, Paul J Park, Seungil Ro
65 [GO] 2021―May―13 Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison? Armando Rojas, Iván Schneider, Cristian Lindner, Ileana Gonzàlez, Miguel Angel Morales
66 [GO] 2021―Apr―28 Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment Cinzia Maria Chinnici, Giovanna Russelli, Matteo Bulati, Vitale Miceli, Alessia Gallo, Rosalia Busà, et al. (+3)
67 [GO] 2021―Apr―21 Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight Isabela Macedo Lopes Vasques-Monteiro, Vanessa Souza-Mello
68 [GO] 2021―Apr―21 Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, Yasser El-Sawaf
69 [GO] 2021―Apr―14 Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges Fares E M Ali, Zuhair M Mohammedsaleh, Mahmoud M Ali, Osama M Ghogar
70 [GO] 2021―Apr―09 COVID-19 and the gastrointestinal tract: source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection? Jacopo Troisi, Giorgia Venutolo, Meritxell Pujolassos Tanyà, Matteo Delli Carri, Annamaria Landolfi, Alessio Fasano
71 [GO] 2021―Apr―06 Risk perception and knowledge of COVID-19 in patients with celiac disease Jamie Zhen, Juan Pablo Stefanolo, María de la Paz Temprano, Caroline L Seiler, Alberto Caminero, Enrique de-Madaria, et al. (+19)
72 [GO] 2021―Apr―06 Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey Natália Sousa Freitas Queiroz, Fábio Vieira Teixeira, Marina Pamponet Motta, Liliana Andrade Chebli, Adriano Akira Ferreira Hino, Camilla de Almeida Martins, et al. (+5)
73 [GO] 2021―Mar―30 COVID-19 and comorbidities of hepatic diseases in a global perspective Aqsa Ahmad, Syeda Momna Ishtiaq, Junaid Ali Khan, Rizwan Aslam, Sultan Ali, Muhammad Imran Arshad
74 [GO] 2021―Mar―30 Coronavirus disease-2019 and the intestinal tract: An overview Gabriela Gama Freire Alberca, Rosa Liliana Solis-Castro, Maria Edith Solis-Castro, Ricardo Wesley Alberca
75 [GO] 2021―Mar―17 How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, Adérson Omar Mourão Cintra Damião, Liliana Andrade Chebli, Márcia Henriques de Magalhães Costa, Rogério Serafim Parra
76 [GO] 2021―Mar―11 Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature Riccardo De Carlis, Ivan Vella, Niccolò Incarbone, Leonardo Centonze, Vincenzo Buscemi, Andrea Lauterio, Luciano De Carlis
77 [GO] 2021―Mar―03 Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China Shui-Sheng Zhang, Li Dong, Gao-Ming Wang, Yuan Tian, Xiao-Fang Ye, Yue Zhao, et al. (+14)
78 [GO] 2021―Mar―03 Interaction between hepatitis B virus and SARS-CoV-2 infections Tian-Dan Xiang, Xin Zheng
79 [GO] 2021―Feb―20 Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms Gao-Feng Zhan, Yue Wang, Ning Yang, Ai-Lin Luo, Shi-Yong Li
80 [GO] 2021―Feb―05 Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings Tarun Sahu, Arundhati Mehta, Yashwant Kumar Ratre, Akriti Jaiswal, Naveen Kumar Vishvakarma, Lakkakula Venkata Kameswara Subrahmanya Bhaskar, Henu Kumar Verma
81 [GO] 2021―Jan―29 Liver injury in the era of COVID-19 Halina Cichoż-Lach, Agata Michalak
82 [GO] 2020―Dec―30 Lipidome is lipids regulator in gastrointestinal tract and it is a life collar in COVID-19: A review Khaled Mohamed Mohamed Koriem
83 [GO] 2020―Dec―25 High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data Luis Antonio Díaz, Francisco Idalsoaga, Macarena Cannistra, Roberto Candia, Daniel Cabrera, Francisco Barrera, et al. (+6)
84 [GO] 2020―Dec―14 Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective Amr Shaaban Hanafy, Sherief Abd-Elsalam
85 [GO] 2020―Nov―27 COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report Anna Sessa, Alessandra Mazzola, Chetana Lim, Mohammed Atif, Juliana Pappatella, Valerie Pourcher, et al. (+2)
86 [GO] 2020―Nov―20 Barriers for resuming endoscopy service in the context of COVID-19 pandemic: A multicenter survey from Egypt Omar Elshaarawy, Sameh Aldesoky Lashen, Nahed A Makhlouf, Doaa Abdeltawab, Mariam Salah Zaghloul, Rasha M Ahmed, et al. (+16)
87 [GO] 2020―Nov―06 Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract Michail Galanopoulos, Aris Doukatas, Maria Gazouli
88 [GO] 2020―Oct―28 Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review Márk Félix Juhász, Klementina Ocskay, Szabolcs Kiss, Péter Hegyi, Andrea Párniczky
89 [GO] 2020―Oct―21 Acute gastrointestinal injury in critically ill patients with COVID-19 in Wuhan, China Jia-Kui Sun, Ying Liu, Lei Zou, Wen-Hao Zhang, Jing-Jing Li, Yu Wang, et al. (+4)
90 [GO] 2020―Oct―14 Management of an endoscopy center during the outbreak of COVID-19: Experience from West China Hospital Yuan Gao, Lian-Song Ye, Jiang Du, Qiong-Ying Zhang, Bing Hu
91 [GO] 2020―Sep―28 Review of inflammatory bowel disease and COVID-19 Keith Sultan, Anjali Mone, Laura Durbin, Samreen Khuwaja, Arun Swaminath
92 [GO] 2020―Sep―27 Review of inflammatory bowel disease and COVID-19 Keith Sultan, Anjali Mone, Laura Durbin, Samreen Khuwaja, Arun Swaminath
93 [GO] 2020―Sep―24 COVID-19 pandemic and challenges in pediatric gastroenterology practice Jamal Kriem, Riad Rahhal
94 [GO] 2020―Aug―28 Etiology and management of liver injury in patients with COVID-19 Rui-Xu Yang, Rui-Dan Zheng, Jian-Gao Fan
95 [GO] 2020―Aug―20 COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract Michail Galanopoulos, Filippos Gkeros, Aris Doukatas, Grigorios Karianakis, Christos Pontas, Nikolaos Tsoukalas, et al. (+3)
96 [GO] 2020―Aug―20 Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan Hu Zhang, Yu-Sheng Liao, Jing Gong, Jing Liu, Heng Zhang
97 [GO] 2020―Jun―14 COVID-19 pandemic: Its impact on liver disease and liver transplantation Tevfik Tolga Sahin, Sami Akbulut, Sezai Yilmaz
98 [GO] 2020―May―20 Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review Ming Han Cha, Miguel Regueiro, Dalbir S Sandhu
99 [GO] 2020―May―20 Liver diseases in COVID-19: Etiology, treatment and prognosis Jian Wu, Shu Song, Hong-Cui Cao, Lan-Juan Li
100 [GO] 2020―Apr―14 SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant Kaveh Hajifathalian, Srihari Mahadev, Robert E Schwartz, Shawn Shah, Kartik Sampath, Felice Schnoll-Sussman, et al. (+4)
 [1] 

100 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.022 sec